October 18, 2024 01:33 PM EDT
Pharma
FDA+

EMA again rec­om­mends against au­tho­riza­tion for PTC Ther­a­peu­tic­s' Translar­na

Katherine Lewin

News Reporter

The Eu­ro­pean Med­i­cines Agency’s hu­man med­i­cines com­mit­tee again de­cid­ed not to rec­om­mend the re­new­al of the con­di­tion­al mar­ket­ing au­tho­riza­tion for PTC …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

A con­ver­sa­tion with No­bel Prize win­ner David Bak­er on the fu­ture of AI in pro­tein de­sign — and be­yond

CVS re­places CEO Karen Lynch with PBM ex­ec David Joyn­er

FDA ap­proves Astel­las' gas­tric can­cer drug Vy­loy ahead of sched­ule

Gilead pulls Trodelvy's ac­cel­er­at­ed la­bel in blad­der can­cer af­ter drug failed con­fir­ma­to­ry study

Se­cre­tive Tree­line Bio­sciences dis­clos­es $421M fi­nanc­ing in fil­ing

sponsored

Join the Gen­Script Biotech Glob­al Fo­rum: Un­lock­ing In­no­va­tions in Cell and Gene Ther­a­pies

A service from the Financial Times